André Janse
Research Subjects
André Janse has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Anne Claire B. van Orten-Luiten
Division of Human Nutrition and Health, Wageningen University & Research, Wageningen, The Netherlands
5 shared publications - Renger F. Witkamp
Division of Human Nutrition and Health, Wageningen University, Stippeneng 4, 6708 WE, Wageningen, The Netherlands
3 shared publications - Elske Maria Brouwer-Brolsma
Division of Human Nutrition and Health, Wageningen University & Research, Wageningen, The Netherlands
2 shared publications R.F. Witkamp
2 shared publications- E. Verspoor
Division of Human Nutrition and Health, Wageningen University and Research Centre, P.O. Box 17, 6700 AA Wageningen, the Netherlands
1 shared publication E.M. Brouwer-Brolsma
1 shared publication
Latest Publications
- Open Access
- 1 August 2025
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 81 (10) , 1-9
A drug-based model to predict hyponatremia in outpatients of a geriatric clinic
Purpose: Chronic hyponatremia in older people is associated with adverse outcomes including gait disturbances, falls, osteoporosis, fractures, cognitive impairment, and cardiovascular disease. Diagnosis in outpatient settings is challenging due to the non-specific nature of its symptoms. While hyponatremia is well-studied in hospitalized patients, little research has focused on outpatient settings. This study aimed to develop a drug-based model to non-invasively predict hyponatremia in older adults attending a geriatric outpatient clinic. Methods: Cross-sectional data from 2181 outpatients aged ≥ 55 were analysed using logistic regression. Polypharmacy, 27 specific drug groups, sex, age, and BMI were considered as potential risk factors. Predictors were selected using stepwise backward logistic regression for the complex model and LASSO regression for the simple model. Internal validation was performed through bootstrapping, and model performance was evaluated by constructing a receiver operating characteristic (ROC) curve. Results: The prevalence of hyponatremia was 10.5%, with higher occurrence in women. The complex model identified predictors including sex, age, BMI, polypharmacy, and 11 drug groups, achieving an area under the curve (AUC) of 0.75, [95% CI 0.72–0.79], indicating a reasonably good ability to distinguish between hypo- and normonatremia. The simple model, including only polypharmacy, had limited predictive performance (AUC = 0.64 [95% CI 0.60–0.68]). Conclusion: The complex, drug-based model predicts hyponatremia risk in outpatients of a geriatric clinic. Timely recognition may prevent inappropriate treatments for undiagnosed cases and associated harms. The model merits further development for clinical use.
- 1 August 2025
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 81 (10) , 1-9
Open AccessA drug-based model to predict hyponatremia in outpatients of a geriatric clinic
Purpose: Chronic hyponatremia in older people is associated with adverse outcomes including gait disturbances, falls, osteoporosis, fractures, cognitive impairment, and cardiovascular disease. Diagnosis in outpatient settings is challenging due to the non-specific nature of its symptoms. While hyponatremia is well-studied in hospitalized patients, little research has focused on outpatient settings. This study aimed to develop a drug-based model to non-invasively predict hyponatremia in older adults attending a geriatric outpatient clinic. Methods: Cross-sectional data from 2181 outpatients aged ≥ 55 were analysed using logistic regression. Polypharmacy, 27 specific drug groups, sex, age, and BMI were considered as potential risk factors. Predictors were selected using stepwise backward logistic regression for the complex model and LASSO regression for the simple model. Internal validation was performed through bootstrapping, and model performance was evaluated by constructing a receiver operating characteristic (ROC) curve. Results: The prevalence of hyponatremia was 10.5%, with higher occurrence in women. The complex model identified predictors including sex, age, BMI, polypharmacy, and 11 drug groups, achieving an area under the curve (AUC) of 0.75, [95% CI 0.72–0.79], indicating a reasonably good ability to distinguish between hypo- and normonatremia. The simple model, including only polypharmacy, had limited predictive performance (AUC = 0.64 [95% CI 0.60–0.68]). Conclusion: The complex, drug-based model predicts hyponatremia risk in outpatients of a geriatric clinic. Timely recognition may prevent inappropriate treatments for undiagnosed cases and associated harms. The model merits further development for clinical use.
- 1 December 2019
- Published by Elsevier in Clinical Nutrition
- Vol. 38 (6) , 2668-2676
Drug use is associated with lower plasma magnesium levels in geriatric outpatients; possible clinical relevance
- 1 December 2019
- Published by Elsevier in Clinical Nutrition
- Vol. 38 (6) , 2668-2676
Drug use is associated with lower plasma magnesium levels in geriatric outpatients; possible clinical relevance
- 1 August 2018
- Published by Elsevier in Clinical Nutrition
- Vol. 37 (4) , 1186-1192
Protein-enriched familiar foods and drinks improve protein intake of hospitalized older patients: A randomized controlled trial
- 1 August 2018
- Published by Elsevier in Clinical Nutrition
- Vol. 37 (4) , 1186-1192
Protein-enriched familiar foods and drinks improve protein intake of hospitalized older patients: A randomized controlled trial
- 1 September 2017
- Published by Elsevier in Clinical Nutrition
- Vol. 36, S31
PT01.6: Drug Use and Serum Magnesium in Dutch Geriatric Outpatients
- 1 September 2017
- Published by Elsevier in Clinical Nutrition
- Vol. 36, S31
PT01.6: Drug Use and Serum Magnesium in Dutch Geriatric Outpatients
- Open Access
- 12 February 2016
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 72 (5) , 605-614
Vitamin D deficiency as adverse drug reaction? A cross-sectional study in Dutch geriatric outpatients
Purpose Adverse drug reactions as well as vitamin D deficiency are issues of public health concern in older people. However, relatively little is known about the impact of drug use on vitamin D status. Our primary aim is to explore associations between drug use and vitamin D status in older people. Furthermore, prevalences of drug use and vitamin D deficiency are estimated. Methods In a population of 873 community-dwelling Dutch geriatric outpatients, we explored the cross-sectional relationships of polypharmacy (≥5 medications concomitantly used), severe polypharmacy (≥10 medications), and use of twenty-one specific drug groups, with serum 25-hydroxyvitamin D (25(OH)D) by analysis of covariance. Results Overall prevalence of polypharmacy was 65 %, of severe polypharmacy 22 %. Depending on the cut-off value, prevalence of vitamin D deficiency was 49 % (<50 nmol/l) or 77 % (<75 nmol/l). Of the patients using a vitamin D supplement, 17 % (<50 nmol/l) or 49 % (<75 nmol/l) were still deficient. In non-users of supplemental vitamin D, after adjustment for age and gender, negative associations were found for severe polypharmacy, metformin, sulphonamides and urea derivatives (SUDs), vitamin K antagonists, cardiac glycosides, loop diuretics, potassium-sparing diuretics, ACE inhibitors, and serotonin reuptake inhibitors; for non-selective monoamine reuptake inhibitors (NSMRIs) the association was positive. The most extreme impacts of drug use on adjusted mean 25(OH)D were −19 nmol/l for SUDs and +18 nmol/l for NSMRIs. Conclusion Drug use should be considered a risk factor for vitamin D deficiency amongst geriatric outpatients.
- 12 February 2016
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 72 (5) , 605-614
Open AccessVitamin D deficiency as adverse drug reaction? A cross-sectional study in Dutch geriatric outpatients
Purpose Adverse drug reactions as well as vitamin D deficiency are issues of public health concern in older people. However, relatively little is known about the impact of drug use on vitamin D status. Our primary aim is to explore associations between drug use and vitamin D status in older people. Furthermore, prevalences of drug use and vitamin D deficiency are estimated. Methods In a population of 873 community-dwelling Dutch geriatric outpatients, we explored the cross-sectional relationships of polypharmacy (≥5 medications concomitantly used), severe polypharmacy (≥10 medications), and use of twenty-one specific drug groups, with serum 25-hydroxyvitamin D (25(OH)D) by analysis of covariance. Results Overall prevalence of polypharmacy was 65 %, of severe polypharmacy 22 %. Depending on the cut-off value, prevalence of vitamin D deficiency was 49 % (<50 nmol/l) or 77 % (<75 nmol/l). Of the patients using a vitamin D supplement, 17 % (<50 nmol/l) or 49 % (<75 nmol/l) were still deficient. In non-users of supplemental vitamin D, after adjustment for age and gender, negative associations were found for severe polypharmacy, metformin, sulphonamides and urea derivatives (SUDs), vitamin K antagonists, cardiac glycosides, loop diuretics, potassium-sparing diuretics, ACE inhibitors, and serotonin reuptake inhibitors; for non-selective monoamine reuptake inhibitors (NSMRIs) the association was positive. The most extreme impacts of drug use on adjusted mean 25(OH)D were −19 nmol/l for SUDs and +18 nmol/l for NSMRIs. Conclusion Drug use should be considered a risk factor for vitamin D deficiency amongst geriatric outpatients.
- Open Access
- 15 August 2009
- Published by Physicians Postgraduate Press, Inc in The Primary Care Companion For CNS Disorders
- Vol. 11 (4) , 172-173
Quetiapine-Induced Bradycardia Without QT Interval Prolongation in an Elderly Woman
- 15 August 2009
- Published by Physicians Postgraduate Press, Inc in The Primary Care Companion For CNS Disorders
- Vol. 11 (4) , 172-173
Open AccessQuetiapine-Induced Bradycardia Without QT Interval Prolongation in an Elderly Woman